BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Treatment
298 results:

  • 1. KIAA0040 enhances glioma growth by controlling the JAK2/stat3 signalling pathway.
    He J; Xue K; Fan F; Li L; Rao X; Liu W; Nie C
    J Cell Mol Med; 2024 Apr; 28(8):e18332. PubMed ID: 38661644
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Expression of stat3 and hypoxia markers in long-term surviving malignant glioma patients.
    Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
    BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of core genes of craniopharyngioma angiogenesis based on single-cell nuclear transcriptome sequencing.
    Zhang J; Xu L; Ye J; Xu C; Wu B; Wu J; Hong T
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):136-141. PubMed ID: 38650143
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/stat3 axis.
    Qiu Y; Pei D; Wang M; Wang Q; Duan W; Wang L; Liu K; Guo Y; Luo L; Guo Z; Guan F; Wang Z; Xing A; Liu Z; Ma Z; Jiang G; Yan D; Liu X; Zhang Z; Wang W
    CNS Neurosci Ther; 2024 Apr; 30(4):e14709. PubMed ID: 38605477
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Generation of human cerebral organoids with a structured outer subventricular zone.
    Walsh RM; Luongo R; Giacomelli E; Ciceri G; Rittenhouse C; Verrillo A; Galimberti M; Bocchi VD; Wu Y; Xu N; Mosole S; Muller J; Vezzoli E; Jungverdorben J; Zhou T; Barker RA; Cattaneo E; Studer L; Baggiolini A
    Cell Rep; 2024 Apr; 43(4):114031. PubMed ID: 38583153
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities.
    Ahirwar K; Kumar A; Srivastava N; Saraf SA; Shukla R
    Int J Biol Macromol; 2024 May; 266(Pt 1):131048. PubMed ID: 38522697
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inhibition of PRMT1 Suppresses the Growth of U87MG-Derived Glioblastoma Stem Cells by Blocking the stat3 Signaling Pathway.
    Yuk N; Jung HJ
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474197
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Antiproliferative effect of Potentilla fulgens on glioblastoma cancer cells through downregulation of Akt/mTOR signaling pathway.
    Kandemir SI; Ipek P
    J Cancer Res Ther; 2023 Oct; 19(7):1818-1824. PubMed ID: 38376284
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. brain Metastases Are Regulated by Immuno-inflammatory Signaling Pathways Governed by stat3, MAPK and Tumor Suppressor p53 Status: Possible Therapeutic Targets.
    Zeller SL; Spirollari E; Dicpinigaitis AJ; Wainwright JV; Hanft SJ; Gandhi CD; Jhanwar-Uniyal M
    Anticancer Res; 2024 Jan; 44(1):13-22. PubMed ID: 38160007
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The correlation among Claudin-9, Tyrosine kinase-2, and Signal transducers and activators of transcription-3 expressions in non-functioning pituitary adenoma and invasiveness.
    Yasen A; Tuoheti M; Tu B; Zhang C; Ding Y; Tang F; Wu Y
    Neuro Endocrinol Lett; 2023 Dec; 44(8):537-546. PubMed ID: 38131177
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Synergistic effect of cryptotanshinone and temozolomide treatment against human glioblastoma cells.
    Zhu S; Guo J; Yu L; Liu J; Chen J; Xin J; Zhang Y; Luo J; Duan C
    Sci Rep; 2023 Dec; 13(1):21835. PubMed ID: 38071213
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating stat3 in glioblastoma.
    Chen Y; Mu Y; Guan Q; Li C; Zhang Y; Xu Y; Zhou C; Guo Y; Ma Y; Zhao M; Ji G; Liu P; Sun D; Sun H; Wu N; Jin Y
    Cell Death Dis; 2023 Nov; 14(11):757. PubMed ID: 37985768
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Combining organotypic tissue culture with light-sheet microscopy (OTCxLSFM) to study glioma invasion.
    Haydo A; Wehle A; Herold-Mende C; Kögel D; Pampaloni F; Linder B
    EMBO Rep; 2023 Dec; 24(12):e56964. PubMed ID: 37938214
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.
    Shin JE; Kim SH; Kong M; Kim HR; Yoon S; Kee KM; Kim JA; Kim DH; Park SY; Park JH; Kim H; No KT; Lee HW; Gee HY; Hong S; Guan KL; Roe JS; Lee H; Kim DW; Park HW
    Mol Cancer; 2023 Nov; 22(1):177. PubMed ID: 37932786
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR.
    Kim S; Park JM; Park S; Jung E; Ko D; Park M; Seo J; Nam KD; Kang YK; Lee K; Farrand L; Kim YJ; Kim JY; Seo JH
    J Exp Clin Cancer Res; 2023 Nov; 42(1):292. PubMed ID: 37924112
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cross-talk between PARN and EGFR-stat3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells.
    Yin J; Seo Y; Rhim J; Jin X; Kim TH; Kim SS; Hong JH; Gwak HS; Yoo H; Park JB; Kim JH
    Cancer Res; 2023 Nov; 83(22):3693-3709. PubMed ID: 37747775
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma.
    Pang F; Zhang L; Li M; Yi X; Wang Y; Yang P; Wen B; Jiang J; Teng Y; Yang X; Chen L; Xu J; Wang L
    Cancer Gene Ther; 2023 Dec; 30(12):1636-1648. PubMed ID: 37726387
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Ruyong formula improves thymus function of CUMS-stimulated breast cancer mice.
    He B; Guo W; Shi R; Hoffman RD; Luo Q; Hu YJ; Gao J
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117164. PubMed ID: 37717843
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway.
    Zhao G; Deng Z; Li X; Wang H; Chen G; Feng M; Zhou Y
    Exp Brain Res; 2023 Oct; 241(10):2409-2418. PubMed ID: 37644332
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Enhancement of Microglia Functions by Developed Nano-Immuno-Synergist to Ameliorate Immunodeficiency for Malignant Glioma treatment.
    Xu M; Cheng Y; Meng R; Yang P; Chen J; Qiao Z; Wu J; Qian K; Li Y; Wang P; Zhou L; Wang T; Sheng D; Zhang Q
    Adv Healthc Mater; 2023 Dec; 12(30):e2301861. PubMed ID: 37573475
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.